The NanoGhost cancer treatment targeted delivery mechanism developed by scientists at Israel’s Technion Institute is truly revolutionary (see here previously).  It enables the dose of existing immunotherapies (e.g., TRAIL) to be reduced by a millionfold, to prevent toxic side effects.

https://www.timesofisrael.com/immunotherapy-drug-now-works-with-a-millionth-of-a-dose-thanks-to-israeli-tech/

https://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.202105701